Platinum-resistant ovarian cancer.3 treatment arms:-PLD and Atezolizumab (anti-PD-L1 mAb)-PLD and Bevacizumab-PLD and Atezolizumab and Bevacizumab.Randomised, open-label. The gene discussed is CD274; the disease is ovarian cancer.